NovaResp Raises $3M
NovaResp, the Halifax developer of technology for treating sleep apnea, has raised a $3 million seed extension round that CEO Hamed Hanafi expects to fund the company through completion of its clinical trials.
The deal builds on a $2 million round NovaResp closed in Dec. 2022 and is led by board member Dr. Neil Smith, along with returning investors Concrete Ventures and Invest Nova Scotia.